Does Methocarbamol Show Up in a Drug Test?

If you take methocarbamol (brand name Robaxin) and have an upcoming drug test, you may be wondering whether the medication could appear on your results or cause you to fail a screening.

In most cases, methocarbamol does not show up on a standard drug test. Routine workplace and employment drug screens are designed to look for specific substances or drug classes included in the test panel, and methocarbamol is not ordinarily one of the substances targeted by standard panels. However, a specialized laboratory test can be designed to look for methocarbamol or its metabolites.

That distinction is important. Whether a medication is detectable and whether a particular drug test is designed to detect it are two different questions.

Methocarbamol is a prescription skeletal muscle relaxant used to help relieve discomfort associated with acute, painful musculoskeletal conditions. Current FDA labeling identifies it as a centrally acting central nervous system depressant with sedative and musculoskeletal-relaxant properties. Its mean plasma elimination half-life in healthy volunteers is about 1 to 2 hours, although clearance can vary between individuals and may be slower in certain medical conditions.

This guide explains how methocarbamol relates to drug testing, including urine drug tests, 5-panel and 10-panel screens, specialized testing, false-positive concerns, dosage questions, and how methocarbamol’s elimination differs from a drug-test detection window.

Does Methocarbamol Show Up on a Drug Test?

Usually, no. Methocarbamol is not routinely included in standard drugs-of-abuse screening panels.

A standard drug test does not test for every prescription medication a person may be taking. Instead, the laboratory tests for particular substances or metabolites that have been selected as targets for that specific panel.

For example, a routine panel may be designed to identify substances such as marijuana metabolites, cocaine metabolites, amphetamines, opioids, or other specified drug classes. The exact substances depend on the panel, laboratory, employer, agency, and testing program.

Methocarbamol is a different type of medication. It is a centrally acting muscle relaxant rather than one of the drug classes ordinarily targeted by routine workplace drug screens.

Federal workplace testing guidance illustrates why the panel itself matters: the testing program specifies authorized substances and analytes rather than screening every possible medication. SAMHSA’s current federal workplace resources provide the applicable testing guidelines and authorized panels.

Therefore, taking prescribed methocarbamol does not normally mean that a routine drug test will report methocarbamol as a positive result.

Why Isn’t Methocarbamol Included in Standard Drug Tests?

The simplest explanation is that drug tests are targeted tests.

A urine drug screen does not generally ask:

“What medications has this person taken?”

Instead, it asks whether particular target substances or their metabolites are present at concentrations relevant to that test.

Methocarbamol does not normally belong to the standard drug classes targeted by routine employment drug screening.

This is why the following distinction is useful:

Medication present in the body ≠ medication included in the drug-test panel.

A person can take a prescription medication that is present in their urine while receiving a negative result on a standard drug screen because the test was never designed to identify that medication.

What Does a Standard Drug Test Look For?

The substances included depend on the test.

A typical drug-screening panel may include some combination of:

• THC or marijuana metabolites
• Cocaine metabolites
• Amphetamines
• Methamphetamine
• Opioids or opiates
• PCP
• Benzodiazepines
• Fentanyl
• Other specified substances

However, 5-panel, 10-panel, 12-panel, and other commercial panels are not necessarily identical from one provider to another.

The name of a panel tells you the general scope, but you should check the actual analytes included by the laboratory or test provider.

SAMHSA’s federal workplace program maintains specific authorized testing panels, while non-federal employers and laboratories may use other testing configurations.

Does Methocarbamol Show Up on a Urine Drug Test?

For a routine urine drug screen, methocarbamol is generally not one of the substances being targeted.

This is an important distinction because methocarbamol and its metabolites are associated with urinary elimination. Official prescribing information states that methocarbamol is metabolized through processes including dealkylation and hydroxylation and that essentially all of its metabolites are eliminated in urine, while only small amounts of unchanged methocarbamol are excreted in urine.

That does not mean a standard urine drug test automatically detects it.

Think of it this way:

Urine contains a substance → the laboratory could potentially test for it.

But:

Urine drug screen does not target that substance → it generally will not be reported as one of the routine drug-screen results.

A laboratory can perform targeted testing for medications that are not part of a routine drugs-of-abuse panel, but that is a different testing situation.

Does Methocarbamol Show Up on a 5-Panel Drug Test?

Methocarbamol is generally not included as a target in a standard 5-panel drug test.

A 5-panel test is designed around a defined group of substances rather than every prescription drug.

The exact panel should always be confirmed with the laboratory or testing provider because commercial test products can differ.

If you are taking methocarbamol as prescribed, the presence of the medication itself does not mean that a standard 5-panel screen should produce a positive result for one of its targeted drug categories.

This is also why it is misleading to say that someone will automatically “fail a drug test” simply because methocarbamol is present in their system.

The correct question is:

Was methocarbamol, or an analyte associated with it, actually included in the ordered test?

For most routine 5-panel workplace screens, the answer is no.

Does Methocarbamol Show Up on a 10-Panel Drug Test?

A standard 10-panel test also does not automatically test for every prescription medication.

Adding more substances to a panel does not mean that every possible muscle relaxant is included.

A 10-panel test may include additional drug classes beyond a 5-panel test, but the actual analytes vary by test manufacturer and laboratory.

Therefore, if someone is asking:

“Will methocarbamol show up on a 10-panel drug test?”

the most accurate answer is:

Usually not, unless the particular panel has been specifically designed to include methocarbamol or a relevant analyte.

This is a much more reliable answer than claiming that every 10-panel test is identical.

Does Methocarbamol 500 mg Show Up on a Drug Screen?

Taking a 500 mg methocarbamol tablet does not normally cause a standard drug screen to become positive for one of the routine drugs being tested.

Methocarbamol tablets are available in 500 mg and 750 mg strengths, according to current labeling.

The important issue is not simply the tablet strength. The test result depends primarily on what the laboratory is testing for and which analytical method is being used.

A 500 mg dose does not turn methocarbamol into an opioid, benzodiazepine, amphetamine, or another standard drug-screen target.

If a laboratory specifically orders methocarbamol testing, however, dosage and timing may become relevant to interpretation.

Does Methocarbamol 750 mg Show Up on a Drug Test?

The same general principle applies to a 750 mg dose.

Methocarbamol 750 mg is not ordinarily a target of standard drugs-of-abuse screening panels simply because the dose is higher.

Current product labeling confirms that 750 mg methocarbamol tablets are an approved dosage form. The medication’s pharmacokinetic behavior, including its elimination half-life, can vary depending on individual characteristics and health status.

A higher dose may affect how much medication is present in the body, but it does not change the basic composition of a drug-test panel.

In other words:

Dose affects drug exposure.

The test panel determines what the laboratory is looking for.

These are related but different concepts.

How Long Does Methocarbamol Stay in Your System?

This is one of the most commonly searched questions associated with methocarbamol drug testing.

Methocarbamol has a relatively short plasma elimination half-life. Current FDA labeling reports a mean plasma elimination half-life of approximately 1 to 2 hours in healthy volunteers.

However, it is important not to turn the half-life into a guaranteed drug-test detection time.

Half-Life Is Not the Same as Detection Window

A drug’s half-life describes how quickly its concentration in the body decreases. It does not automatically tell you exactly how long a laboratory can detect the drug.

Drug-test detection depends on factors such as:

• The substance being tested
• The test method
• The laboratory assay
• The specimen type
• The laboratory’s cutoff or reporting criteria
• Dose and dosing frequency
• Individual metabolism
• Age
• Liver function
• Kidney function
• Whether the test detects the parent drug or a metabolite

This distinction is particularly important with methocarbamol.

The official labeling states that essentially all methocarbamol metabolites are eliminated in urine, while only small amounts of unchanged methocarbamol are excreted there.

Therefore, saying that methocarbamol has a 1–2 hour half-life does not mean you can automatically calculate a universal urine drug-test detection window.

How Methocarbamol Is Metabolized

Methocarbamol undergoes metabolism in the body before its metabolites are eliminated.

According to current prescribing information, methocarbamol is metabolized through dealkylation and hydroxylation, with conjugation also likely. Essentially all metabolites are eliminated through urine, while only small amounts of unchanged methocarbamol are excreted in urine.

This pharmacokinetic information helps explain why methocarbamol can be associated with urinary elimination without being part of a routine urine drug screen.

The laboratory still needs to have a test designed to identify the relevant compound or metabolite.

Can Age Affect How Long Methocarbamol Stays in the Body?

Yes.

The FDA labeling reports that the mean elimination half-life was somewhat longer in elderly healthy volunteers than in a younger healthy comparison group.

This illustrates an important point:

There is no single elimination timeline that applies identically to everyone.

Age, health status, dosing pattern, and organ function can influence pharmacokinetics.

Can Kidney Problems Affect Methocarbamol Clearance?

Kidney function can also matter when considering methocarbamol pharmacokinetics.

Official labeling reports that clearance was reduced in patients with renal impairment undergoing maintenance hemodialysis, although the reported mean elimination half-life in that group was similar to that of normal subjects in the cited study.

This is another reason not to promise a precise detection period based only on the medication’s half-life.

Can Liver Problems Affect Methocarbamol Clearance?

Yes.

This is an especially important distinction because hepatic impairment can substantially alter methocarbamol clearance.

The FDA labeling reports that in patients with cirrhosis related to alcohol use, mean total clearance was reduced by approximately 70% compared with matched individuals without that impairment, and the reported mean elimination half-life was longer.

Therefore, a person’s medical condition can influence how methocarbamol is processed.

That does not mean the medication will suddenly appear on a routine drug screen, but it does mean that generalized statements about exactly when methocarbamol leaves the body should be treated cautiously.

Does Methocarbamol Show Up as Another Drug?

A routine drug screen should not be expected to report methocarbamol as another drug simply because you took methocarbamol.

Methocarbamol is not metabolized into the standard drugs typically targeted by common drugs-of-abuse panels.

However, an unexpected screening result should not be interpreted solely from the medication name.

If a screening test produces an unexpected positive result, the appropriate next step is to have the result evaluated under the testing program’s procedures and, where appropriate, confirmed using a more specific laboratory method.

This distinction between an initial screening result and definitive testing is important because screening assays are designed for efficient detection of specified targets rather than complete chemical identification of everything present in a specimen.

Can Methocarbamol Be Detected by a Specialized Test?

Yes, methocarbamol can be specifically tested for when a laboratory orders an appropriate targeted assay.

This is different from a routine employment drug screen.

A standard drug screen typically uses a predefined panel of target substances. A specialized toxicology or medication-monitoring test can be designed with a different purpose and may include prescription medications that are not part of routine workplace screening.

The key distinction is:

Routine drug screen: looks for specified drugs or drug classes.

Targeted medication testing: looks for a particular medication, metabolite, or group of medications.

Therefore, it is technically possible for methocarbamol to be detected in a laboratory specimen even though it is not normally included in a standard workplace drug panel.

This distinction is especially relevant in clinical toxicology, medication-monitoring, forensic investigations, or other situations where a healthcare professional has a specific reason to order expanded testing.

What Is the Difference Between a Drug Screen and a Confirmatory Test?

Drug testing can involve different analytical stages.

Screening Test

An initial screen is often designed to efficiently identify whether a specimen may contain a target substance at or above a specified threshold.

Screening methods can include immunoassays and other analytical approaches depending on the laboratory and testing program.

Confirmatory or Definitive Testing

More specific laboratory techniques can be used when confirmation is required.

Methods such as GC-MS and LC-MS/MS can provide highly specific identification and quantification of targeted compounds.

However, an important point is often overlooked:

Using a sophisticated laboratory method does not automatically mean that the laboratory is testing for methocarbamol.

The test still needs to include methocarbamol or an appropriate analyte in its ordered panel or analytical scope.

A highly sensitive instrument cannot report a medication that was not included among the substances being analyzed.

Can Methocarbamol Cause a False Positive Drug Test?

This question requires some nuance.

Methocarbamol is not generally expected to produce a positive result for a routine drug-of-abuse panel simply because you are taking it.

However, methocarbamol has been associated with interference in certain laboratory tests that are not the same thing as a routine workplace drug screen.

For example, prescribing information includes laboratory-test interference information involving certain urine tests such as tests for 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).

This is an important distinction.

A laboratory interference does not necessarily mean:

“Methocarbamol causes false positives on ordinary employment drug tests.”

Instead, it means that methocarbamol may interfere with particular clinical laboratory assays.

Therefore, when discussing false positives, it is more accurate to identify the specific test involved rather than making a broad claim about all drug screens.

What Should You Do If a Drug Test Is Unexpectedly Positive?

If you receive an unexpected result while taking prescription medication, do not assume that the medication definitely caused the result.

Instead:

1. Tell the appropriate testing professional or medical review professional about all prescription medications you are taking.
2. Provide medication information when requested.
3. Ask which substance or analyte produced the result.
4. Determine whether the result was an initial screening result or a confirmed result.
5. Follow the testing program’s procedures for confirmatory testing or medical review.

In regulated workplace testing, the testing program has established procedures for specimen collection, laboratory analysis, review, and reporting. SAMHSA provides current federal workplace testing resources and guidance for these programs.

Is Methocarbamol a Narcotic?

No. Methocarbamol is not an opioid narcotic.

It is a centrally acting muscle relaxant with central nervous system depressant effects.

Calling methocarbamol a narcotic can create unnecessary confusion because narcotics commonly refers to opioid drugs such as morphine and related substances.

Methocarbamol belongs to a different pharmacologic category.

Is Methocarbamol a Controlled Substance?

Current U.S. DailyMed labeling lists methocarbamol with DEA Schedule: None, meaning it is not federally scheduled as a controlled substance under the Controlled Substances Act.

However, the fact that a medication is not federally scheduled does not mean it is completely free of effects or risks. Methocarbamol can cause central nervous system effects such as drowsiness or dizziness, and it should be used according to the prescribing information and healthcare professional’s instructions.

For drug-testing purposes, the key point is that methocarbamol is not one of the standard federally scheduled drugs that routine workplace panels are designed around.

What Drug Class Is Methocarbamol?

Methocarbamol is a centrally acting skeletal muscle relaxant.

Current labeling describes it as a central nervous system depressant with sedative and musculoskeletal-relaxant properties.

It is prescribed to help manage symptoms associated with acute, painful musculoskeletal conditions.

This classification helps explain why methocarbamol does not fit naturally into the drug classes usually included in standard drugs-of-abuse screening panels.

Do Muscle Relaxers Show Up on Drug Tests?

This question cannot be answered with a simple yes or no because muscle relaxers are not one uniform testing category.

Different medications have different chemical structures, metabolites, pharmacokinetics, and testing considerations.

For example:

Medication	General category	Routine drug-screen issue
Methocarbamol	Centrally acting muscle relaxant	Generally not included in standard panels
Cyclobenzaprine	Skeletal muscle relaxant	Not routinely targeted by standard panels
Carisoprodol	Skeletal muscle relaxant	May be included in some specialized/expanded testing
Baclofen	Muscle relaxant	Not typically part of routine standard panels
Tizanidine	Centrally acting muscle relaxant	Not typically part of routine standard panels

The exact result depends on the medication and the specific test.

This is why an article about methocarbamol should not simply say “muscle relaxers do not show up on drug tests.” That statement is too broad.

Methocarbamol vs. Carisoprodol on a Drug Test

Methocarbamol and carisoprodol are both muscle relaxants, but they should not be treated as interchangeable substances for drug-testing purposes.

Carisoprodol is metabolized to meprobamate, and some expanded testing programs can specifically target carisoprodol or meprobamate.

Methocarbamol has a different pharmacologic and metabolic profile.

This comparison is useful because people searching for information about methocarbamol may encounter articles discussing “muscle relaxers” generally and mistakenly assume that the testing characteristics of one medication apply to all of them.

They do not.

Does a Prescription for Methocarbamol Change a Drug-Test Result?

A prescription does not change the chemical composition of a drug test.

If a test does not target methocarbamol, taking it as prescribed does not normally make that test positive for methocarbamol.

However, prescription information can be important if an unexpected result occurs or if the testing program specifically asks about medications.

If you are undergoing a formal employment, medical, legal, or clinical drug test, follow the instructions provided by the testing organization and disclose prescription medications when required.

Do not stop a prescribed medication solely because you are worried about a drug test without discussing the decision with your healthcare professional.

Does Methocarbamol Show Up in Blood Testing?

Methocarbamol can be measured in blood when an appropriate analytical test is specifically performed.

That does not mean ordinary blood testing automatically checks for methocarbamol.

As with urine testing, the laboratory needs an appropriate analytical method and a reason or order to test for the compound.

Official labeling documents methocarbamol’s plasma pharmacokinetics, including its relatively short mean elimination half-life in healthy volunteers.

Therefore, a blood test designed specifically for methocarbamol is a different situation from a standard workplace drug screen.

Does Methocarbamol Show Up in Saliva or Oral Fluid Testing?

Methocarbamol is not normally part of standard workplace oral-fluid drug panels simply because it is a prescription muscle relaxant.

Oral-fluid testing, like urine testing, depends on the substances included in the particular test.

SAMHSA currently provides separate federal guidance and procedures for urine and oral-fluid workplace testing, demonstrating that specimen type and testing program both matter.

A specialized oral-fluid assay would be a different situation from a routine workplace panel.

Does Methocarbamol Show Up in Hair Testing?

Hair testing is also a specialized form of toxicology testing and should not automatically be treated as equivalent to a standard urine drug screen.

Whether methocarbamol can be identified in a hair specimen depends on whether the laboratory uses a validated analytical method that includes the medication or its relevant analytes.

For this reason, it is better to avoid blanket statements such as “methocarbamol stays in hair for X days” unless a specific validated testing method and source support that claim.

How Long Does Methocarbamol Stay in Urine?

Methocarbamol and its metabolites are eliminated through urine, but there is no single universal urine detection window that can be guaranteed for every person and every laboratory test.

Current labeling confirms that essentially all methocarbamol metabolites are eliminated in urine and that only small amounts of unchanged drug are excreted there.

The important distinction is:

Urinary elimination does not equal a guaranteed urine drug-test detection period.

A specialized test may have different capabilities from a routine drug screen, and laboratory cutoffs and analytical methods matter.

Therefore, it is not scientifically responsible to promise that methocarbamol will always be undetectable after a specific number of hours.

What Factors Can Affect Methocarbamol Clearance?

Several factors can influence how methocarbamol behaves in the body.

Dose

The amount taken can affect overall drug exposure.

Repeated Dosing

Repeated doses can produce a different concentration profile from a single dose.

Age

Older adults may have somewhat different pharmacokinetic behavior. FDA labeling reports a slightly longer mean elimination half-life in elderly healthy volunteers than in the younger comparison group.

Liver Function

Hepatic impairment can substantially reduce methocarbamol clearance. In patients with cirrhosis related to alcohol use, labeling reports markedly reduced clearance and a longer mean elimination half-life.

Kidney Function

Renal impairment can affect clearance and the handling of metabolites.

Individual Metabolism

People do not all process medications at exactly the same rate.

For all of these reasons, a generic internet detection chart should not be treated as a guarantee for an individual drug test.

Will You Fail a Drug Test if You Take Methocarbamol?

Taking methocarbamol as prescribed does not normally cause a positive result on a standard drug screen because methocarbamol is not ordinarily one of the substances being tested.

However, no article can guarantee the result of an unknown laboratory test.

The exact test panel matters.

If the testing organization uses a standard workplace panel that does not include methocarbamol, the medication would not ordinarily be reported as a target drug.

If a specialized medication or toxicology test specifically includes methocarbamol, the situation is different.

What If Your Employer Uses a Drug Test?

For employment testing, ask the testing organization what type of test is being administered if that information is available to you.

Federal workplace testing programs have defined requirements and authorized panels, while private employers may use different testing programs depending on applicable laws, policies, and circumstances. SAMHSA’s current workplace resources distinguish federal testing requirements and provide current HHS guidelines and testing information.

If you have been prescribed methocarbamol, keep your medication information available and follow the employer’s or testing provider’s instructions.

Frequently Asked Questions

Does methocarbamol show up on a drug test?

Usually not on a standard drug screen. Methocarbamol is not ordinarily included among the substances targeted by routine workplace drug panels. A specialized test can be different.

Does Robaxin show up on a drug test?

Robaxin is the brand name for methocarbamol. Like generic methocarbamol, it is generally not a target of standard drugs-of-abuse panels.

Does methocarbamol show up on a urine drug test?

Not normally on a routine urine drug screen. Although methocarbamol metabolites are eliminated in urine, the laboratory must specifically test for the relevant compound or analyte to report it.

Does methocarbamol show up on a 5-panel drug test?

Generally no. Methocarbamol is not ordinarily one of the standard targets of a 5-panel drugs-of-abuse screen.

Does methocarbamol show up on a 10-panel drug test?

Usually not, although the exact contents of a 10-panel test vary. Check the laboratory’s analyte list if you need to know exactly what is being tested.

Does methocarbamol 500 mg show up on a drug screen?

A 500 mg dose does not normally cause a positive result on a standard drug screen simply because methocarbamol is present in the body.

Does methocarbamol 750 mg show up on a drug screen?

The same principle applies to 750 mg. Dose does not automatically make methocarbamol part of a standard drug-testing panel.

Is methocarbamol a narcotic?

No. Methocarbamol is a centrally acting muscle relaxant, not an opioid narcotic.

Is methocarbamol a controlled substance?

Current U.S. DailyMed labeling lists methocarbamol with no DEA Schedule.

Can methocarbamol cause a false positive?

Methocarbamol is not generally expected to cause a positive result for a routine drugs-of-abuse panel. However, the medication can interfere with certain specific laboratory assays, so the exact test matters.

How long does methocarbamol stay in your system?

Its mean plasma elimination half-life is approximately 1–2 hours in healthy volunteers, but this should not be interpreted as a guaranteed drug-test detection window. Clearance can differ based on individual factors.

Can a specialized test detect methocarbamol?

Yes. A laboratory can use a targeted test when methocarbamol or its metabolites are specifically included in the analytical scope.

Should I stop taking methocarbamol before a drug test?

Do not stop a prescribed medication solely because you are concerned about a drug test unless your healthcare professional tells you to do so. Follow your prescription and the instructions provided by the testing organization.